RMD 2.45% $31.74 resmed inc

Resmed's (ASX:RMD) continuous positive airway pressure (CPAP)...

  1. 85 Posts.
    lightbulb Created with Sketch. 11

    Resmed's (ASX:RMD) continuous positive airway pressure (CPAP) devices andmasks treat sleep apnea.

    CPAP has long been thegold standard for treating obstructive sleep apnea (OSA), and ResMed is theleading global supplier.
    But as of today, ResMed shares have fallen from $40.13 to $23.51,which would be 71% profits for the trade if it recovers back to $40.13.
    The sell-off was triggered by disappointing gross margins andgrowing investor concerns about competition from a new wave of GLP-1weight-loss drugs.
    However, GLP-1 facesseveral headwinds, including supply constraints, lagging real-world efficacy,side effects, low drug compliance, high costs, and a possible lack of insurancecoverage.

    Its attractive valuation currently outweighs the risks it faces.
    This is a great buyingopportunity for me, bought (ASX:RMD) today.

 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$31.74
Change
0.760(2.45%)
Mkt cap ! $19.67B
Open High Low Value Volume
$31.75 $31.96 $31.70 $10.38M 326.6K

Buyers (Bids)

No. Vol. Price($)
8 913 $31.74
 

Sellers (Offers)

Price($) Vol. No.
$31.76 1437 10
View Market Depth
Last trade - 10.43am 05/06/2024 (20 minute delay) ?
Last
$31.77
  Change
0.760 ( 2.45 %)
Open High Low Volume
$31.75 $31.96 $31.72 25170
Last updated 11.03am 05/06/2024 ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.